Introduction: SAPHO is a rare syndrome of osteoarticular disorders with associated skin manifestations. The classic constellation of symptoms includes synovitis, acne, pustulosis, hyperostosis and osteomyelitis. Estimated prevalence is 1-4/10,000, but the syndrome is underdiagnosed due to its variable presentation and lack of formal diagnostic criteria. SAPHO is a diagnosis of exclusion and conditions such as infectious osteomyelitis and bone tumours must be eliminated first. We present a case of SAPHO, mistakenfor spinal tuberculosis (TB). Case description: A 67-year-old Caribbean man with a history of type 2 diabetes mellitus and multiple prolapsed discs requiring surgical fixation presented in 2014 with severe back pain, swinging fevers and weight loss. A CT scan showed sclerosis of T9/10 vertebrae with corresponding bone oedema on an MRI spine. He commenced induction treatment for TB based on radiological features and travel history. Two months later, an MRI spine showed progressive inflammation at T10/11. Blood and tissue samples were negative for acid fast bacilli. Mycobacterium cultures, Interferon-gamma release assay (IGRA) and PCR were negative. However, treatment for TB was continued for a further ten months. Three months later, he re-presented with thoracic back pain and night sweats. MRI showed new inflammation at T6/7 and L3/4 reported as probable osteomyelitis. IGRA, blood and tissue cultures remained negative. Meanwhile, the patient suffered nine episodes of synovitis affecting knees and wrists. Knee X-rays showed end-stage hypertrophic osteoarthritic changes with severe osteophytosis. Synovial biopsies showed inflammatory changes but no evidence of TB. The patient re-presented in 2018 with back pain, sternoclavicular (SC) joint tenderness, painful knee swelling, night sweats and weight loss. Blood and synovial fluid cultures were negative, with calcium pyrophosphate crystals detected in synovial fluid. USS scan of the SC joint showed floridly active right-sided synovitis and synovial thickening on the left. CRP was 350 and he was treated with broad spectrum antibiotics for two weeks for presumed septic arthritis. Rheumatology review was requested when he failed to improve. His constellation of symptoms (synovitis, hyperostosis, osteitis and a history of a pustular rash) suggests a diagnosis of SAPHO. He commenced a weaning prednisolone regime and given zoledronic acid to good effect. Recurrence of symptoms occurred at low dose prednisolone, so he was given IM steroids and commenced onmethotrexate. Discussion: SAPHO is underdiagnosed due its variable presentation and the need to first exclude infection and malignancy. The patient's radiological features consistent with spinal TB and risk of TB exposure delayed diagnosis,despite negativeserologyand cultures. Itisimportanttobeawarethatthefullconstellationofsymptomsmaynot be evidentatthetimeofpresentation,orindeedatallinthecourseofthecondition; our patient reported a prior history of a pustular rash on the soles of his feet,althoughtherewasnoclinicalevidenceofthisatthetimeofreview. Involvement of classically affected joints, including anterior chest wall and thoracic spine, or skin involvement should increase clinical suspicion of SAPHO. NSAIDs and corticosteroids are first line therapy, with DMARDs, biologicalagentsandbisphosphonatesusedtomaintainremission. Key learning points: Practitioners must consider the possibility of SAPHO, particularly in those with symptoms of osteomyelitis but no identifiable pathogen orwho do not respond to antibiotic therapy. High inflammatory markers or high fevers do not preclude its diagnosis. As such, it is important to exclude infection, including osteomyelitis and septic arthritis, and malignancy prior to making adiagnosis. Clinicians should also be aware that the patient may not present with the full SAPHO syndrome; close review of past medical history and questioning about unreported episodes of synovitis or rash may be required to make the diagnosis. Conflicts of interest: The authors have declared no conflicts of interest.
Introduction: Fever is a cardinal manifestation of both autoinflammatory disease and infection. Distinguishing the two is a familiar challenge to the rheumatologist. This case report describes a young female presenting with recurrent fevers, rash and inflammatory arthritis. The case illustrates the importance of a careful travel and social history in the diagnosis and management of a patient presenting with recurrent fevers, particularly in an eraof globalisation and air travel. Case description: A 19-year-old Caucasian female presented to her local district general hospital with episodic fevers, rash, arthralgia, and abdominal pain. Past medical history included autoimmune liver disease, treated with azathioprine. She had no relevant family history, took no medications other than azathioprine, was a non-smoker and had no allergies. On presentation she was pyrexic with a temperature of 40 C, and tachycardic (120bpm), with a BP of 108/59. She was synovitic in her wrists, knees and ankles. Pustular skin lesions were noted on the lower limbs, spreading to the groin, upper limbs and the face, and evolving into haemorrhagic bullae. Baseline bloods including cultures, and skin swabs were taken. Despite broad-spectrum antimicrobials and acyclovir, she continued to spike temperatures. Her symptoms briefly resolved on two occasions before recurring. Blood cultures and skin swabs were sterile and varicella PCR negative. She had high acute-phase reactants with a CRP of 238 and a ferritin of > 1000. Autoimmune screen was positive for only anti-smooth muscle antibodies. The lack of response to anti-microbials andelevatedferritinraised suspicionofautoinflammatorypathology and prompted inpatient transfer toa tertiary rheumatology service. After transfer further investigations included a PETCT which demonstrated splenomegaly (25cm) with multiple metabolically active lesions. Three pieces of further history were elicited: (1) Four weeks prior to symptom onset, the patient reported a new sexual partner; (2) The patient has a pet cat which frequently scratched her legs, and; (3) She travelled to southern Spain four months prior to admission, and regularly walked her tick-infested grandparent's dog through shrubland. She subsequently underwentscreening for syphilis, HIV and gonococcus, molecular testing for Bartonella species, and serological assessment for tick-borne illnesses. She was positive for non-Lyme Borrelia species. A diagnosis of tick-borne relapsing fever (TBRF) was made, and treatment with doxycycline induced arapid clinical response. Discussion: Autoinflammatory diseases are characterised by recurrent episodes of inflammation due to defects in innate immunity. The absence of autoantibodies means recognition of clinical phenotype is crucial. In this patient, the presence of synovitis, high fevers, raised inflammatory markers and serum ferritin fit with adult-onset Still's disease (AOSD). However, the rash was atypical. The rash in AOSD is salmon-pink, nonpruritic and typically occurs in the upper arms, abdomen and thighs. Additionally, although the spleen is often enlarged, focal lesions arerare. Infections were considered, particularly with background immunosuppression and liver disease. Negative cultures and failure to improve with antibiotics suggested a non-infectious cause. Detailed history identified risk factors for infections undetected by standard microbial tests. Disseminated gonococcal infection can present with pustular acral rash and asymmetric polyarthralgia for which PCR is standard diagnosis. Bartonellosis or cat-scratch disease usually presents 3-12 days after a scratch with tender local unilateral lymphadenopathy, malaise and fever. Bacillary angiomatosis can occur in immunocompromised patients and can present with subcutaneous nodules which haemorrhage or ulcerate. Bartonella is a fastidious gram-negative rod that requires special conditions for culture so is not routinely performed. There is no commercial serology test, so the specimen was sent to Porton Down for PCR, which was negative. A diagnosis of TBRF was reached due to exposure to ticks during travel to southern Spain and positive non-Lyme Borrelia serology. The species of tick found in this region are Ixodes Ricinus and Ornithodoros which are carriers of Borrelia and Babesia. TBRF's incubation period is 3-18 days and presents with fever, arthritis, rash, abdominal pain and hepatosplenomegaly. Symptoms are episodic with periods of remission. The patient's symptomatology was consistent with non-Lyme Borrelia species, but the incubation period was significantly prolonged. Samples have been sent formolecular Borrelia testingand blood films. Key learning points: Rheumatologists are often asked to review patients with recurrent fever. An awareness of atypical infectious differentials can be crucial to making the correct diagnosis. Relapsing fever is an umbrella term used to describe the characteristic pattern of infection caused by spirochetes of the genus Borrelia and can be transmitted by ticks or lice. Other infectious causes of recurrent fever include malaria and rat-bite fever. An important non-infectiouscause is lymphoma. When trying to isolate the causative pathogen, it is important to note that standard microbial cultures are often insufficient for atypical pathogens. In the case of our patient, both spirochete and rickettsia are bacterial tickborne illness which are undetected by standard cultures. Additionally, the lack of response to antibiotics does not exclude infection; rather it may reflect an inappropriate choice of antibiotics. Thus, an awareness of which pathogens respond to which antibiotics is crucial in the timely and effectivetreatment of infection. This case illustrates the importance of a careful clinical history in diagnosis and treatment. Particularly in the context of a suspected infection, an extensive travelandsocialhistoryisimportant inestablishingriskof exposure to pathogens either directly or indirectly via vectors. In this case Bartonellosis was initially suspected before negative PCR made non-Lyme Borreliosis a more likely diagnosis. Fortunately doxycycline is the first-line treatment forboth of these organisms. Rheumatologists are familiar with the predisposition of immunocompromised patients to atypical pathogens. These atypical infections are frequently harder to detect, therefore a rheumatologist must keep these organisms in the back of their mind when considering sources of infection in immunocompromised patients.
Conflicts of interest:
The authors have declared no conflicts of interest. Introduction: Adult-onset Still's disease, an auto-inflammatory disease, is well described in the literature and tends to respond well to IL-1 blockade. A sub-group of adult patients may present with some of the typical symptoms and findings whichare commonly associated with autoinflammatory conditionsbut may not fulfil the criteria to obtain aspecific diagnosis. It has been reported in the literature that these patients may represent an 'undifferentiated systemic autoinflammatory disorder' and case reports support the use of anakinra as a viable treatment option in this sub-group. Case description: A 54-year-old female presented to rheumatology in 2014 with a two year history of recurrent episodes of sore throat, pyrexia, night sweats, polyarthralgia, headaches and bilateral episcleritis. Each episode recurred monthly and lasted three to five days before resolving. This patient's condition did not fulfil Yamaguchi's criteria for adult-onset Still's disease. Investigations revealed an elevated ferritin which ranged between 500-2700, CRP greater than 300, ESR greater than 120. Extensive investigations excluded an infective or malignant cause and included virology, autoimmune and vasculitis screen, IGRA, blood cultures, transthoracic echo, ultrasound abdomen, CT chest/abdomen/pelvis and CT-PET scan. Genetic screening for hereditary autoinflammatory disorders was negative. Serum immunoglobulins (including IgD) and serum protein electrophoresis was unremarkable. The patient's symptoms and inflammatory markers were responsive to high dose oral prednisolone, however, her symptoms recurred with steroid tapering. The patient was commenced on Methotrexate 25mg once weekly by subcutaneous injection to facilitate steroid weaning in 2015. The patient initially responded well to Methotrexate and was successfully weaned off steroids completely, she remained asymptomatic for two years. In 2017, she experienced frequent flares of her condition and continued to have active episcleritis on ophthalmological assessment. The patient required multiple courses of oral prednisolone to control her regular flares. The decision was taken to commence the patient onanakinra 100mg once daily subcutaneous injections one year ago in combination with methotrexate. The patient's condition has remained in remission since commencing anakinra in 2018 with resolution of her symptoms, episcleritis and serum inflammatory markers and is nolonger requiring oral prednisolone. Discussion: This patient exhibited signs and symptoms which are commonly associated with auto-inflammatory conditions. Due to the clinical phenotypeand negativegenetic testing, this patient did not fulfil anycriteria to be diagnosed with a specific auto-inflammatory disease. She did not fulfil Yamaguchi's criteria for adult-onset Still's disease. It is likely that this patient represents a case of 'atypical adult-onset Still's disease' or an 'undifferentiated systemic autoinflammatory disorder' which is supported by herexcellent responseto IL-1 blockade in the form of anakinra. Key learning points: This case highlights the importance of considering 'undifferentiated systemic autoinflammatory disorder' or 'atypical adultonset Still's disease' as a potential diagnosis for the subgroup of patients presenting atypically who do not fulfil any current classification or diagnostic criteria for a specific autoinflammatory disease. This case also illustrates that IL-1 blockade is potentially a viable treatment option in these patients.
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FEVER, DYSPNOEA AND A RAISED CRP: JUST ANOTHER CHEST SEPSIS?
Edward Davies 1 , and Vijay Hajela 1 1 Rheumatology, Brighton and Sussex University Hospitals NHS Foundation Trust, Brighton, United Kingdom Introduction: Autoinflammatory conditions can arise in patients presenting on the medical take. Patients presenting with an inflammatory response, fever and organ dysfunction are usually (and appropriately) managed as sepsis until proven otherwise. However, a suspicion should be maintained for alternative diagnoses when there is no improvement with conventional antimicrobial therapy. We present a case of a young woman presenting with polyserositis with a wide differential diagnosis including infection, autoimmunity and malignancy. She was treated successfully with colchicine. Subsequent genetic analysis at the Royal Free hospital for fever syndromes has not found a pre-described genetic polymorphism. Case description: A 39-year-old woman presented to A&E with dyspnoea,night sweats,lethargyandrightupperquadrantpain.Herpastmedical history included hypothyroidism and two years of intermittent diarrhoea. This diarrhoea was associated with a raised faecal calprotectin. Subsequent investigation with colonoscopy and MRI small bowel were normal. Other past history included pleurisy felt to be secondary to a lower respiratory tract infection aged 38 and a right knee effusion aged 15. She was born inthe UKbut had aGreekmother. Examination revealed reduced breath sounds in the bases which were dull to percuss, normal heart sounds and mild abdominal distension. There was no peripheral oedema. Observations showed oxygen saturations of 90% on air, BP 90/50, HR 120 and a pyrexia of 38 C. Blood results showed araised ALT of 100and CRP 40.She was initially treated withantibiotics for aworking diagnosis of atypical pneumonia. Her respiratory failure deteriorated and a CTPA two days later showed bilateral pleural effusions, a massive pericardial effusion with impending tamponade and a right upper lobe PE. A CT CAP show moderate ascites but noevidence of malignancy orlymphoma. Pericardiocentesis showed a reactive picture with no organisms grown and normal cytopathology of the fluid. Pleural and ascitic fluid were also drained and she was commenced on LMWH for the PE. Virology, microbiological and autoimmune screens were unremarkable. CRP at this stage had risen to78 as had the ALT to 1400. 6 days after admission, antibiotics were stopped shewas commenced on colchicine 1mg bd. Within 48 hours she rapidly improved both clinically and biochemically. Discussion:Since the index admission genetic analysis has shown sheis HLA B51 negative and she has no recognised genetic polymorphism associated with a periodic fever syndrome. 20 months since admission she has made a good recovery and is stable on colchicine 1mg od with no recurrence of the pleural and pericardial effusions. She has had one further episode of diarrhoea for 2 weeks associated with a raised faecal calprotectin and red macular rashes on her torso. Anticoagulation forthe PE hasbeen stopped. Polyserositis in the absence of infection or malignancy is uncommon and autoinflammatory and autoimmune aetiologies should be considered. This case highlights the importance of keeping a broad mind in patients presenting in an unusual way or when they do not respond to initial treatment. Autoinflammatory conditions are characterised by marked inflammation affecting the skin, serosal surfaces and synovium among others. Her history of colitis is intriguing. There are case reports of patients with familial Mediterranean fever presenting with serositis but she was negative for FMF on further genetic testing. Similarly she did not prove to have any of the genes that have so far been recognised as causing a periodic fever syndrome. We did considerBehc¸et's butshedenied ahistoryof recurrent oral orgenital ulceration or iritis and there was no family history. However Behc¸et's can lead to inflammatory bowel disease and this remains an intriguing possibility.
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